Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Bandar AlAqeel & Howard C. Margolese. (2013) Remission in Schizophrenia: Critical and Systematic Review. Harvard Review of Psychiatry 20:6, pages 281-297.
Read now
Read now
Alkomiet Hasan, Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F. Gattaz, Florence Thibaut & Hans-Jürgen Möller. (2012) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. The World Journal of Biological Psychiatry 13:5, pages 318-378.
Read now
Read now
Articles from other publishers (8)
Dan Siskind, Erin Gallagher, Karl Winckel, Samantha Hollingworth, Steve Kisely, Joseph Firth, Christoph U Correll & Wade Marteene. (2021) Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis. Schizophrenia Bulletin 47:4, pages 948-958.
Crossref
Crossref
Zhang Cheng, Yanbo Yuan, Xue Han, Lei Yang, Xin Zeng, Fude Yang, Zheng Lu, Chuanyue Wang, Hong Deng, Jingping Zhao, Yu-Tao Xiang, Christoph U. Correll & Xin Yu. (2019) Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, “real world” clinical trial. Psychiatry Research 273, pages 631-640.
Crossref
Crossref
Marco Pozzi, Dario Cattaneo, Sara Baldelli, Serena Fucile, Annalisa Capuano, Carmela Bravaccio, Liberata Sportiello, Silvana Bertella, Fabiana Auricchio, Renato Bernardini, Carmen Ferrajolo, Giuseppe Guastella, Elisa Mani, Carla Carnovale, Simone Pisano, Concetta Rafaniello, Maria Pia Riccio, Renata Rizzo, Maria Grazia Scuderi, Serena Sperandeo, Laura Villa, Antonio Pascotto, Massimo Molteni, Francesco Rossi, Sonia Radice & Emilio Clementi. (2015) Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings. European Journal of Clinical Pharmacology 72:3, pages 285-293.
Crossref
Crossref
Maarten Bak, Annemarie Fransen, Jouke Janssen, Jim van Os & Marjan Drukker. (2014) Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis. PLoS ONE 9:4, pages e94112.
Crossref
Crossref
Anja Cerovecki, Richard Musil, Ansgar Klimke, Florian Seemüller, Ekkehard Haen, Rebecca Schennach, Kai-Uwe Kühn, Hans-Peter Volz & Michael Riedel. (2013) Withdrawal Symptoms and Rebound Syndromes Associated with Switching and Discontinuing Atypical Antipsychotics: Theoretical Background and Practical Recommendations. CNS Drugs 27:7, pages 545-572.
Crossref
Crossref
Jihyung Hong, Diego Novick, Roberto Brugnoli, Jamie Karagianis, Martin Dossenbach & Josep Maria Haro. (2012) Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study. BMC Psychiatry 12:1.
Crossref
Crossref
Anitha Mukundan, Guy Faulkner, Tony Cohn & Gary Remington. (2010) Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Bruce J Kinon, Lei Chen, Haya Ascher-Svanum, Virginia L Stauffer, Sara Kollack-Walker, Wei Zhou, Shitij Kapur & John M Kane. (2009) Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia. Neuropsychopharmacology 35:2, pages 581-590.
Crossref
Crossref